Provided by Tiger Fintech (Singapore) Pte. Ltd.

Savara Inc

3.22
+0.16005.23%
Post-market: 3.220.00000.00%16:05 EDT
Volume:1.34M
Turnover:4.12M
Market Cap:556.25M
PE:-6.66
High:3.24
Open:3.05
Low:2.81
Close:3.06
Loading ...

Company Profile

Company Name:
Savara Inc
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
59
Office Location:
1717 Langhorne Newtown Road,Suite 300,Langhorne,Pennsylvania,United States
Zip Code:
19047
Fax:
- -
Introduction:
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.

Directors

Name
Position
Robert Neville
Chairman and Chief Executive Officer
David A. Ramsay
Director
Joseph S. McCracken
Director
Matthew Pauls
Director
Nevan Elam
Director
Richard J. Hawkins
Director
Yuri Pikover
Director

Shareholders

Name
Position
Robert Neville
Chairman and Chief Executive Officer
Taneli Jouhikainen
President and Chief Operating Officer
David Lowrance
Chief Financial Officer